PUBMED FOR HANDHELDS

Journal Abstract Search


588 related items for PubMed ID: 15480901

  • 1. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

  • 2. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, Takechi S, Fujishima M.
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [Abstract] [Full Text] [Related]

  • 4. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 5. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
    Kanno Y, Witt M, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H.
    Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
    [Abstract] [Full Text] [Related]

  • 6. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
    Kobayashi Y, Fujii K, Hiki Y, Tateno S.
    Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
    [Abstract] [Full Text] [Related]

  • 7. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
    Suzuki S, Joh K.
    Clin Exp Nephrol; 2004 Jun; 8(2):109-16. PubMed ID: 15235927
    [Abstract] [Full Text] [Related]

  • 8. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
    Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K.
    Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
    [Abstract] [Full Text] [Related]

  • 9. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
    Medicina (B Aires); 2007 Aug; 67(5):445-50. PubMed ID: 18051227
    [Abstract] [Full Text] [Related]

  • 10. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 11. [Effects of steroid therapy in IgA nephropathy].
    Ohashi T, Shimokawahara H, Fukumoto M, Azuma K, Uchida Y, Tokuda Y, Ito H, Yasumoto Y, Yamashita W, Harada R.
    Fukuoka Igaku Zasshi; 1992 May; 83(5):209-15. PubMed ID: 1612550
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day.
    Suzuki T, Yamamoto T, Ohura M, Fujigaki Y, Yonemura K, Kimura M, Hishida A.
    Clin Exp Nephrol; 2004 Sep; 8(3):243-9. PubMed ID: 15480902
    [Abstract] [Full Text] [Related]

  • 13. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C, Del Vecchio L, Locatelli F.
    G Ital Nefrol; 2002 Sep; 19(5):523-8. PubMed ID: 12439840
    [Abstract] [Full Text] [Related]

  • 14. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D, Ahuja M, Shortland JR, Brown CB.
    Nephrol Dial Transplant; 1995 Sep; 10(7):1173-81. PubMed ID: 7478120
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 16. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
    Kennoki T, Ishida H, Yamaguchi Y, Tanabe K.
    Transplantation; 2009 Oct 15; 88(7):935-41. PubMed ID: 19935466
    [Abstract] [Full Text] [Related]

  • 17. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J.
    Q J Med; 1985 Oct 15; 57(222):677-88. PubMed ID: 4080957
    [Abstract] [Full Text] [Related]

  • 18. Corticosteroid therapy in patients with IgA nephropathy and impaired renal function.
    Tamura S, Ueki K, Ideura H, Tsukada Y, Maezawa A, Kawai H, Wakamatsu R, Yano S, Nojima Y, Naruse T.
    Clin Nephrol; 2001 Mar 15; 55(3):192-5. PubMed ID: 11316238
    [Abstract] [Full Text] [Related]

  • 19. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.
    J Nephrol; 2005 Mar 15; 18(6):690-5. PubMed ID: 16358226
    [Abstract] [Full Text] [Related]

  • 20. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
    Chábová V, Tesar V, Zabka J, Rychlík I, Merta M, Jirsa M, Stejskalová A, Stejskal J.
    Cas Lek Cesk; 1996 Dec 18; 135(24):803-6. PubMed ID: 9072300
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.